Main Article Content
Pharmaceutical care, Pharmaceutical services, Community pharmacies, SARS-Cov-2
Background: Immunochromatographic rapid tests in pharmacies allow the discovery of specific antibodies against SARS-CoV-2 or viral antigens and provide a broader and more effective screening of the virus. However, in many countries, this process is still not well defined. In this sense, the perception of pharmacists about these screening practices presents an overview of how the service is being carried out in the country. Objective: This study was to evaluate the performance of rapid immunochromatographic tests and their clinical results in community pharmacies in northern Brazil. Method: A retrospective study was carried out between May 2020 and December 2021 in community pharmacies in the northern region of Brazil. Participants were 18 years of age or older, of both sexes, who spontaneously sought the SARS-CoV-2 rapid testing service at pharmacies located in the municipality of Belem and who had had close contact with the virus or symptoms infection-related. Data were expressed as median and range or as frequency of occurrence. Chi-square t-test and Fisher’s exact test were used to compare variables. The accepted significance level was 5%. This study was approved by the Research Ethics Committee (number: 4,865,206). Results: A total of 78,849 patients were recruited into the study. Most patients, 37,847 (48%), were tested antibody positive for SARS-CoV-2. There were no severe signs and symptoms of the disease. The results showed the great demand for carrying out the rapid test in pharmacies and these places could contribute to the understanding of this health establishment, to curb the speed of SARS-CoV-2 dissemination. Conclusion: This study showed the demand for rapid tests for SARS-CoV-2 in pharmacies, as well as the large number of patients identified with the disease. Thus, these places must exercise a workforce and obtain organized actions to collaborate with the rest of the health system, reducing the overload of urgent and emergency units, as well as the risk of contamination that seek them
Suspende os efeitos do $ 2º do art. 69 e do art. 70 da Resolução de Diretoria Colegiada – RDC nº 44 de 17 de agosto de 2009. Available in: https://in.gov.br/web/dou/-/resolucao-rdc-n-377-de-28-de-abril-de-2020-254429215. Acess em: 22 dez 2022.
2. Prazuck T, Colin M, Giachè S, et al. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip. PLoS One. 2020;15(9):e0237694. https://doi.org/10.1371/journal.
3. Döhla M, Boesecke C, Schulte B, et al. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity. Public Health. 2020;182:170-172. https://doi.org/10.1016/j.puhe.2020.04.009
4. Li Z, Yi Y, Luo X, et al. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J Med Virol. 2020;92(9):1518-1524. https://doi.org/10.1002/jmv.25727
5. Al-Quteimat OM, Amer AM. SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm. 2021;17(2):480-482.
6. Baratta F, Visentin GM, Ravetto Enri L, et al. Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence. Int J Environ Res Public Health. 2021;18(5):2302. https://
7. Bragazzi NL, Mansour M, Bonsignore A, et al. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharmacy. 2020;8(3):140. https://
8. de Souza MFR, de Sena MPM, Oliveira CM, et al. Analysis of the clinical practice of the pharmacist in a community pharmacy: A Cross-sectional Study from Brazil. Pharm Pract (Granada). 2022;20(2):2658. https://doi.org/10.18549/PharmPract.2022.2.2658
9. Fitzgerald TJ, Kang Y, Bridges CB, et al. Integrating pharmacies into public health program planning for pandemic influenza
10. Zheng SQ, Yang L, Zhou PX, et al. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 2021;17(1):1819-1824. https://doi.org/10.1016/j.sapharm.2020.03.012
11. Mundodan J, Hasnain S, Khogali H, et al. Validation of rapid antibody (IgG-IgM) test kit for SARS-CoV-2 infection in Qatar. J Public Health Res. 2021;11(1):2421. https://doi.org/10.4081/jphr.2021.2421
12. Cassaniti I, Novazzi F, Giardina F, et al. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. J Med Virol. 2020;92(10):1724-1727. https://doi.
13. Wan WY, Lim SH, Seng EH. Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. Ann Acad Med Singap. 2020;49(7):523-526. https://doi.org/10.47102/annals-acadmedsg.2020120
14. Hasan SS, Kow CS, Razi Zaidi ST. Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures? Res Social Adm Pharm. 2021;17(2):456-459. https://doi.org/10.1016/j.sapharm.2020.04.033
15. Salgado TM, Rosenthal MM, Coe AB, et al. Primary healthcare policy and vision for community pharmacy and pharmacists in the United States. Pharm Pract (Granada). 2020;18(3):2160. https://doi.org/10.18549/PharmPract.2020.3.2160
16. Ung COL. Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm. 2020;16(4):583-586. https://doi.org/10.1016/j.sapharm.2020.02.003
17. Payne K, Unni EJ, Jolley B. Impact of dispensing Services in an Independent Community Pharmacy. Pharmacy. 2019;7(2):44. https://doi.org/10.3390/pharmacy702004418. Rajiah K, Sivarasa S, Maharajan MK. Impact of pharmacists’ interventions and patients’ decision on health outcomes in terms
of medication adherence and quality use of medicines among patients attending Community pharmacies: a systematic review. Int J Environ Res Public Health. 2021;18(9):4392. https://doi.org/10.3390/ijerph18094392
19. World Health Organization - WHO. Coronavirus disease (COVID-19) pandemic [Internet]. Geneva: World Health Organization; 2019 [cited 2020 Apr 26]. Available from: https://www.who.int/emergencies/ diseases/novel-coronavirus-2019.
20. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically Ill patients in the Seattle Region — case series. N Engl J Med. 2020;382(21):2012-2022. https://doi.org/10.1056/NEJMoa2004500
21. Wang Z, Yang B, Li Q, et al. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769-777. https://doi.org/10.1093/cid/ciaa272
22. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
23. Jin X, Lian J-S, Hu J-H, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002-1009. https://doi.org/10.1136/gutjnl-2020-320926
24. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72.314 cases from the chinese center for disease control and prevention. JAMA. 2020;323(13):1239-
25. Gautier JF, Ravussin Y. A new symptom of COVID-19: loss of taste and smell. Obesity. 2020;28(5):848. https://doi.org/10.1002/oby.22809
26. Schuit E, Veldhuijzen IK, Venekamp RP, et al. Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. BMJ. 2021;374:n1676. https://doi.
27. Scheiblauer H, Filomena A, Nitsche A, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARSCoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 2021;26(44):2100441. https://doi.org/10.2807/1560-
28. Schuit E, Venekamp RP, Veldhuijzen IK, et al. Accuracy and usability of saliva and nasal rapid antigen self-testing for detection of SARS-CoV-2 infection in the general population: a head-to-head comparison. medRxiv. 2021. https://doi.org/10.1101/202
29. Deerain J, Druce J, Tran T, et al. Assessment of the Analytical Sensitivity of 10 Lateral Flow Devices against the SARS-CoV-2 Omicron Variant. J Clin Microbiol. 2022;60(2):e0247921. https://doi.org/10.1128/jcm.02479-21
30. Cavalcante JR, Cardoso-dos-Santos AC, Bremm JM, et al. COVID-19 no Brasil: evolução da epidemia até a semana epidemiológica 20 de 2020. Epidemiologia e Serviços de Saúde. 2020;29(4):e2020376. https://doi.org/10.5123/s1679-49742020000400010
31. Croda JHR, Garcia LP. Resposta imediata da Vigilância em Saúde à epidemia da COVID-19. Epidemiologia e Serviços de Saúde. 2020;29(1):e2020002. https://doi.org/10.5123/S1679-49742020000100021